Skip to search formSkip to main contentSkip to account menu

TRK Inhibitor AZD6918

Known as: AZD6918 
An orally available liquid suspension containing the tropomyosin receptor kinase (Trk) inhibitor AZD6918 with potential antineoplastic activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
TrkB activation by brain-derived neurotrophic factor (BDNF) contributes to chemo-resistance in neuroblastoma (NB). AZD6918 is a… 
Highly Cited
2011
Highly Cited
2011
Purpose: TrkB has been involved in poor cancer outcome. TrkB mutations have been reported in non–small cell lung cancer. In this… 
2011
2011
Purpose: TrkB has been involved in poor cancer outcome. TrkB mutations have been reported in non– small cell lung cancer. In this…